haloperidol has been researched along with cholecystokinin in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (48.94) | 18.7374 |
| 1990's | 20 (42.55) | 18.2507 |
| 2000's | 3 (6.38) | 29.6817 |
| 2010's | 1 (2.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, XZ; Mocchetti, I | 2 |
| Britton, DR; Buckley, M; Curzon, P; Nadzan, A; Tufano, M; Yahiro, L | 1 |
| Ibii, N; Ikeda, M; Kihara, T; Matsushita, A | 1 |
| Schiffmann, SN; Vanderhaeghen, JJ | 1 |
| Monzani, E; Panerai, AE; Panza, G; Penati, G; Sacerdote, P | 1 |
| Benoliel, JJ; Catelon, J; De Vitry, F; Hamon, M; Hillion, J; Thibault, J | 1 |
| Ashby, CR; Minabe, Y; Wang, RY | 1 |
| Beinfeld, MC; Garver, DL | 1 |
| Cottingham, SL; Crawley, JN; Montpied, P; Paul, SM; Pickar, D; Shimotake, TK | 1 |
| de Montigny, C; Debonnel, G; Gaudreau, P; Quirion, R | 1 |
| Beinfeld, MC; Garver, DL; Yao, JK | 1 |
| Beinfeld, MC; Bissette, G; Fibiger, HC; MacLennan, AJ; Nemeroff, CB; Radke, JM; Vincent, SR | 1 |
| Hu, XT; Wang, RY | 1 |
| Zafirov, DH | 1 |
| Zetler, G | 4 |
| Agnati, LF; Battistini, N; Benfenati, F; Calza, L; Fuxe, K; Giardino, L; Guidolin, D; Ruggeri, M; Vanderhaeghen, JJ; Zoli, M | 1 |
| Kato, T; Takita, M | 1 |
| Casamenti, F; Florian, A; Magnani, M; Pepeu, G | 1 |
| De Witte, P; Gewiss, M; Goldman, S; Roques, B; Swanet, E; Vanderhaeghen, JJ | 1 |
| Chase, TN; Cohen, SL; Knight, M; Tamminga, CA | 1 |
| Mishra, RK | 1 |
| Frey, P | 1 |
| Kovács, GL; Penke, B; Szabó, G; Telegdy, G | 1 |
| Grace, M; Kneip, J; Levine, AS; Morley, JE; Murray, SS | 1 |
| Chang, RS; Chen, TB; Lotti, VJ; Martin, GE | 1 |
| Levine, AS; Morley, JE; Rowland, NE | 1 |
| Beinfeld, MC; Gysling, K | 1 |
| Battaini, F; Faccini, E; Govoni, S; Locatelli, P; Pasinetti, G; Trabucchi, M | 1 |
| Borison, RL; Diamond, BI; Hitri, A; Pasinetti, G | 1 |
| Krauss, J; Meyer, DK | 1 |
| Levine, AS; Morley, JE | 1 |
| Kuribara, H | 1 |
| Corrigall, WA; Higgins, GA; Joharchi, N; Sellers, EM; Wang, Y | 1 |
| Rasmussen, K | 1 |
| Christoffersen, CL; Meltzer, LT; Razmpour, A; Serpa, KA | 1 |
| Felicio, LF; Nasello, AG; Palermo-Neto, J; Silva, AM; Tieppo, CA | 1 |
| Lau, SM; Tang, F | 1 |
| Audisio, D; Mauri, MC; Panerai, AE; Panza, G; Rudelli, R; Sacerdote, P; Sicaro, A; Vanni, S | 1 |
| Feifel, D; Reza, T; Robeck, S | 1 |
| Lindefors, N; Marcus, MM; Nomikos, GG; Svensson, TH; Zachrisson, O | 1 |
| Feifel, D; Priebe, K; Shilling, PD | 1 |
| Feifel, D; Shilling, PD | 1 |
| Aracil-Fernández, A; Berbel, P; Manzanares, J; Navarrete, F; Navarro, D; Ortega-Álvaro, A | 1 |
2 review(s) available for haloperidol and cholecystokinin
| Article | Year |
|---|---|
Minireview. Stress induced eating.
Topics: Animals; Bombesin; Bruxism; Cholecystokinin; Corticotropin-Releasing Hormone; Feeding and Eating Disorders; Feeding Behavior; Food Preferences; Haloperidol; Humans; Hyperphagia; Latency Period, Psychological; Lesch-Nyhan Syndrome; Mastication; Nail Biting; Narcotics; Receptors, Dopamine; Reward; Spiperone; Stress, Physiological; Sucking Behavior | 1983 |
CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
Topics: Animals; Anxiety; Brain; Cholecystokinin; Dopamine; Haloperidol; Humans; Neurons; Pyrazoles; Receptors, Cholecystokinin; Schizophrenia | 1994 |
1 trial(s) available for haloperidol and cholecystokinin
| Article | Year |
|---|---|
Cholecystokinin, dopamine and schizophrenia.
Topics: Adult; Cholecystokinin; Dopamine; Female; Haloperidol; Homovanillic Acid; Humans; Male; Neurons; Schizophrenia; Time Factors | 1990 |
44 other study(ies) available for haloperidol and cholecystokinin
| Article | Year |
|---|---|
Dopaminergic regulation of cholecystokinin mRNA content in rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benztropine; Blotting, Northern; Brain; Cerebral Cortex; Cholecystokinin; Cocaine; Corpus Striatum; Dopamine; Haloperidol; Kinetics; Male; Mesencephalon; Organ Specificity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; RNA, Messenger | 1992 |
Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Cholecystokinin; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Macaca fascicularis; Male; Mice; Peptide Fragments; Rats; Sulpiride | 1992 |
Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
Topics: Animals; Benzodiazepinones; Ceruletide; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Male; Phenylurea Compounds; Potassium; Proglumide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Vagotomy | 1992 |
Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
Topics: Animals; Cholecystokinin; Corpus Striatum; Dizocilpine Maleate; DNA Probes; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Male; N-Methylaspartate; Rats; Rats, Sprague-Dawley; RNA Probes | 1992 |
Lesion of the nigrostriatal pathway induces cholecystokinin messenger RNA expression in the rat striatum. An in situ hybridization histochemistry study.
Topics: Animals; Autoradiography; Benzazepines; Cholecystokinin; Corpus Striatum; Dopamine; Enkephalins; Haloperidol; Histocytochemistry; In Situ Hybridization; Neural Pathways; Oligonucleotides; Rats; Rats, Wistar; RNA, Messenger; Substantia Nigra | 1992 |
Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients.
Topics: Adolescent; Adult; beta-Endorphin; Cholecystokinin; Female; Haloperidol; Humans; Male; Monocytes; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Vasoactive Intestinal Peptide | 1992 |
Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons.
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Brain Stem; Cells, Cultured; Cholecystokinin; Dopamine; Female; Haloperidol; Hypothalamus; Immunohistochemistry; Neurons; Phenotype; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase | 1991 |
The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Clozapine; Devazepide; Dopamine; Haloperidol; Male; Mesencephalon; Neurons; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reference Values | 1991 |
Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response.
Topics: Adult; Cholecystokinin; Female; Haloperidol; Humans; Lithium; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1991 |
Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration.
Topics: Animals; Cholecystokinin; Gene Expression Regulation; Haloperidol; Locus Coeruleus; Male; Nucleic Acid Hybridization; Oligonucleotides; Rats; Rats, Inbred Strains; RNA, Messenger; Substantia Nigra; Tegmentum Mesencephali; Tyrosine 3-Monooxygenase | 1990 |
Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
Topics: Animals; Autoradiography; Cholecystokinin; Dopamine; Electrophysiology; Haloperidol; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Septal Nuclei; Time Factors | 1990 |
Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat.
Topics: Administration, Oral; Animals; Brain Chemistry; Cholecystokinin; Haloperidol; Male; Neurotensin; Radioimmunoassay; Rats; Rats, Inbred Strains; Time Factors | 1989 |
Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Cholecystokinin; Clozapine; Corpus Striatum; Dibenzazepines; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide | 1989 |
Haloperidol, chlorpromazine and lithium chloride antagonize the excitatory action of forskolin and of some gut peptides on guinea-pig myenteric neurones.
Topics: Action Potentials; Animals; Bombesin; Chlorides; Chlorpromazine; Cholecystokinin; Colforsin; Guinea Pigs; Haloperidol; Lithium; Lithium Chloride; Myenteric Plexus; Vasoactive Intestinal Peptide | 1988 |
Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cholecystokinin; Clonidine; Haloperidol; Humans; Male; Mice; Oligopeptides; Stereotyped Behavior; Thioxanthenes; Trifluoperazine | 1985 |
Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.
Topics: Aging; Animals; Apomorphine; Brain; Cholecystokinin; Haloperidol; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Tyrosine 3-Monooxygenase | 1985 |
Cholecystokinin system in striatal-nigral neuronal networks: infusion of quinolinic acid into rat striatum.
Topics: Animals; Cholecystokinin; Corpus Striatum; Enzyme-Linked Immunosorbent Assay; gamma-Aminobutyric Acid; Haloperidol; Male; Pyridines; Quinolinic Acids; Rats; Rats, Inbred Strains; Sincalide; Substantia Nigra | 1989 |
An analysis of cholecystokinin-induced increase in acetylcholine output from cerebral cortex of the rat.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholecystokinin; Haloperidol; Male; Rats; Rats, Inbred Strains; Sincalide | 1987 |
Psychopharmacological profile of cholecystokinin using the self-stimulation and the drug discrimination paradigms.
Topics: Amphetamine; Animals; Apomorphine; Chlorpromazine; Cholecystokinin; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Rats; Rats, Inbred Strains; Self Stimulation | 1985 |
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Cholecystokinin; Extinction, Psychological; Female; Haloperidol; Humans; Hypnotics and Sedatives; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Stereotyped Behavior; Tetragastrin | 1982 |
Modulation of CNS dopamine receptors by peptides.
Topics: Animals; Behavior, Animal; Brain; Cholecystokinin; Corpus Striatum; Haloperidol; Limbic System; Male; Mesencephalon; Motor Activity; MSH Release-Inhibiting Hormone; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Cholecystokinin; Receptors, Dopamine; Spiperone; Synaptic Transmission | 1983 |
Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Cholecystokinin; Clozapine; Haloperidol; Male; Rats; Rats, Inbred Strains; Sincalide; Tetragastrin | 1983 |
Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Cholecystokinin; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Humans; Male; Methyltyrosines; Mice; Naloxone; Receptors, Dopamine; Sincalide; Stereotyped Behavior | 1981 |
Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
Topics: Animals; Anticonvulsants; Ceruletide; Cholecystokinin; Diazepam; Haloperidol; Harmine; Isoniazid; Male; Mice; Mice, Inbred Strains; Seizures; Semicarbazides; Sincalide | 1981 |
Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
Topics: Animals; Anticonvulsants; Catalepsy; Central Nervous System Depressants; Ceruletide; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Receptors, Dopamine; Sincalide; Sleep; Stereotyped Behavior | 1981 |
Peptidergic regulation of stress-induced eating.
Topics: Animals; Appetite Depressants; Atropine; Bombesin; Carbachol; Cholecystokinin; Enkephalin, Methionine; Enkephalins; Feeding Behavior; Haloperidol; Humans; Isoproterenol; Male; Muscimol; Naloxone; Norepinephrine; Peptide Fragments; Peptides; Phentolamine; Quipazine; Rats; Rats, Inbred Strains; Sincalide; Stress, Psychological | 1982 |
Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
Topics: Animals; Body Temperature Regulation; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Morphine; Peptide Fragments; Sincalide; Time Factors | 1982 |
Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions.
Topics: Animals; Binding, Competitive; Brain; Cholecystokinin; Drug Implants; Guinea Pigs; Haloperidol; Hydroxydopamines; Iodine Radioisotopes; Male; Mice; Oxidopamine; Receptors, Cell Surface; Receptors, Cholecystokinin; Tegmentum Mesencephali | 1983 |
Failure of chronic haloperidol treatment to alter levels of cholecystokinin in the rat brain striatum and olfactory tuberclenucleus accumbens area.
Topics: Animals; Brain Chemistry; Cholecystokinin; Corpus Striatum; Haloperidol; Male; Nucleus Accumbens; Olfactory Nerve; Rats; Rats, Inbred Strains | 1984 |
Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ceruletide; Cholecystokinin; Corpus Striatum; Dopamine; Haloperidol; Male; Metabolism; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1984 |
Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
Topics: alpha-Methyltyrosine; Animals; Brain; Cholecystokinin; Dopamine; Drug Interactions; Extrapyramidal Tracts; Haloperidol; Male; Methyltyrosines; Parkinson Disease; Rats; Rats, Inbred Strains; Reserpine | 1984 |
Dopamine modulates cholecystokinin release in neostriatum.
Topics: Animals; Apomorphine; Calcium; Caudate Nucleus; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Kainic Acid; Putamen; Rats; Receptors, Dopamine; Tetrodotoxin; Veratridine | 1983 |
Peptidergic control of insulin-induced feeding.
Topics: Animals; Atropine; Blood Glucose; Bombesin; Cholecystokinin; Feeding Behavior; Haloperidol; Insulin; Male; Naloxone; Peptides; Rats; Rats, Inbred Strains | 1981 |
Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
Topics: Animals; Behavior, Animal; Ceruletide; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Time Factors | 1995 |
The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Cocaine; Conditioning, Operant; Cues; Devazepide; Discrimination, Psychological; Dopamine Antagonists; Food; Haloperidol; Heroin; Male; Morphine; Narcotics; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Self Administration | 1994 |
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Topics: Animals; Apomorphine; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Indoles; Male; Meglumine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substantia Nigra; Tegmentum Mesencephali | 1993 |
Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
Topics: Analysis of Variance; Animals; Apomorphine; Cholecystokinin; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Rats; Rats, Wistar; Sincalide; Stereotyped Behavior | 1995 |
The effect of haloperidol on met-enkephalin, beta-endorphin, cholecystokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging.
Topics: Aging; Animals; beta-Endorphin; Cholecystokinin; Corpus Striatum; Enkephalin, Methionine; Haloperidol; Hypothalamus; Male; Pituitary Gland; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Behavioral Symptoms; beta-Endorphin; Case-Control Studies; Chi-Square Distribution; Cholecystokinin; Female; Haloperidol; Humans; Leukocytes, Mononuclear; Male; Neuropeptides; Regression Analysis; Schizophrenia; Severity of Illness Index; Treatment Outcome; Vasoactive Intestinal Peptide | 1998 |
Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Ceruletide; Cholecystokinin; Gastrointestinal Agents; Haloperidol; Injections, Subcutaneous; Male; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reflex, Startle; Tetragastrin | 1999 |
Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation.
Topics: Animals; Antipsychotic Agents; Cholecystokinin; Clozapine; Gene Expression Regulation; Haloperidol; Hippocampus; Male; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tachykinins; Transcription, Genetic | 2000 |
Startle and sensorimotor gating in rats lacking CCK-A receptors.
Topics: Acoustic Stimulation; Amphetamine; Animals; Apomorphine; Brain; Cholecystokinin; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Male; Motor Activity; Neural Inhibition; Rats; Rats, Inbred OLETF; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Reflex, Startle | 2001 |
Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
Topics: Animals; Antipsychotic Agents; Cholecystokinin; DNA-Binding Proteins; Down-Regulation; Early Growth Response Protein 1; Gene Expression Regulation; Haloperidol; Immediate-Early Proteins; Neostriatum; Neurons; Nucleus Accumbens; Rats; Rats, Inbred OLETF; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; RNA, Messenger; Transcription Factors; Up-Regulation | 2002 |
Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.
Topics: Animals; Cannabinoid Receptor Antagonists; Central Nervous System Agents; Cerebral Cortex; Cholecystokinin; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Immunohistochemistry; Male; Methylphenidate; Mice, Knockout; Neurons; Parvalbumins; Peptide Fragments; Piperidines; Prepulse Inhibition; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Risperidone; Time Factors | 2015 |